JP2004528320A5 - - Google Patents

Download PDF

Info

Publication number
JP2004528320A5
JP2004528320A5 JP2002577827A JP2002577827A JP2004528320A5 JP 2004528320 A5 JP2004528320 A5 JP 2004528320A5 JP 2002577827 A JP2002577827 A JP 2002577827A JP 2002577827 A JP2002577827 A JP 2002577827A JP 2004528320 A5 JP2004528320 A5 JP 2004528320A5
Authority
JP
Japan
Prior art keywords
alkyl
het
aryl
compound
female sexual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002577827A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004528320A (ja
Filing date
Publication date
Priority claimed from GBGB0107751.0A external-priority patent/GB0107751D0/en
Application filed filed Critical
Publication of JP2004528320A publication Critical patent/JP2004528320A/ja
Publication of JP2004528320A5 publication Critical patent/JP2004528320A5/ja
Withdrawn legal-status Critical Current

Links

JP2002577827A 2001-03-28 2002-03-19 医薬活性化合物 Withdrawn JP2004528320A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0107751.0A GB0107751D0 (en) 2001-03-28 2001-03-28 Pharmaceutically active compounds
PCT/IB2002/000854 WO2002079203A1 (en) 2001-03-28 2002-03-19 Imidazo-triazine derivatives as pde 5 inhibitors

Publications (2)

Publication Number Publication Date
JP2004528320A JP2004528320A (ja) 2004-09-16
JP2004528320A5 true JP2004528320A5 (https=) 2005-06-30

Family

ID=9911744

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002577827A Withdrawn JP2004528320A (ja) 2001-03-28 2002-03-19 医薬活性化合物

Country Status (8)

Country Link
EP (1) EP1395589A1 (https=)
JP (1) JP2004528320A (https=)
AU (1) AU2002241211A1 (https=)
BR (1) BR0208463A (https=)
CA (1) CA2442329A1 (https=)
GB (1) GB0107751D0 (https=)
MX (1) MXPA03005990A (https=)
WO (1) WO2002079203A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7456184B2 (en) 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
CA2462200A1 (en) 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7354923B2 (en) 2001-08-10 2008-04-08 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
DE10229778A1 (de) * 2002-07-03 2004-01-29 Bayer Ag Neue Verwendung von Imidazotriazinonen
JP2006219374A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Pde7阻害作用を有するイミダゾトリアジノン誘導体
DK1697371T3 (da) * 2003-12-19 2007-09-17 Bristol Myers Squibb Co Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
TW200528455A (en) * 2003-12-19 2005-09-01 Bristol Myers Squibb Co Azabicyclic heterocycles as cannabinoid receptor modulators
US7683060B2 (en) 2006-08-07 2010-03-23 Incyte Corporation Triazolotriazines as kinase inhibitors
ME02372B (me) 2006-11-22 2016-06-20 Incyte Holdings Corp Imidazotriazini i imidazopiramidini kao inhibitori kinaze
WO2009143211A2 (en) 2008-05-21 2009-11-26 Incyte Corporation Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
EA025304B1 (ru) 2010-02-03 2016-12-30 Инсайт Холдингс Корпорейшн ИМИДАЗО[1,2-b][1,2,4]ТРИАЗИНЫ В КАЧЕСТВЕ c-Met ИНГИБИТОРОВ
CN102372730B (zh) * 2010-08-19 2014-03-26 山东轩竹医药科技有限公司 桥环取代的磷酸二酯酶抑制剂
CN102382129B (zh) * 2010-08-19 2014-02-26 山东轩竹医药科技有限公司 螺环取代的磷酸二酯酶抑制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US6362178B1 (en) * 1997-11-12 2002-03-26 Bayer Aktiengesellschaft 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
US6503908B1 (en) * 1999-10-11 2003-01-07 Pfizer Inc Pharmaceutically active compounds
DE10010067A1 (de) * 2000-03-02 2001-09-06 Bayer Ag Neue Imidazotriazinone und ihre Verwendung

Similar Documents

Publication Publication Date Title
JP2004527510A5 (https=)
JP2004528320A5 (https=)
JP2003128673A5 (https=)
JP2017537949A5 (https=)
JP2016527217A5 (https=)
JP2004523585A5 (https=)
JP2004531563A5 (https=)
JP2010523522A5 (https=)
JP2004518651A5 (https=)
DE69925970D1 (de) Pyrazolopyrimidinone cGMP PDE5 Inhibitoren zur Behandlung der sexuellen Dysfunktion
MX2010001677A (es) Derivados de 4-(9-(3,3-difluorociclopentil)-5,7,7-trimetil-6-oxo-6 ,7,8,9-tetrahidro-5h-pirimido[4,5-b][1,4]diazepin-2-ilamino)-3-me toxibenzamida como inhibidores de las proteinas cinasas humanas plk1 a plk4 para el tratamiento de enfermedades proli
RU2000113729A (ru) Гетероциклические соединения для ингибирования секреции желудочной кислоты, способы их получения и их фармацевтические компоозиции
EA200200337A1 (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛО[4,3-d]ПИРИМИДИНА
JP2016510038A5 (https=)
JP2004528349A5 (https=)
JP2002535407A5 (https=)
RU2002129557A (ru) Производные 8-хинолинксантина и 8-изохинолинксантина в качестве ингибиторов фосфоэстеразы pde5
JP2004527560A5 (https=)
RU2016141645A (ru) ИНГИБИТОРЫ TrkA КИНАЗЫ, ОСНОВАННЫЕ НА НИХ КОМПОЗИЦИИ И СПОСОБЫ
TW201105675A (en) Compounds and compositions for the treatment of parasitic diseases
JP2004517070A5 (https=)
JP2006506443A5 (https=)
JP2015522018A5 (https=)
JP2017513887A5 (https=)
UY25795A1 (es) Procedimiento para preparar pirazolopirimidinonas que inhiben la guanosina 3',5'- monofosfato cíclico fodfodiesterasa 5 (gmpc pde5).